Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury
- 27 February 2007
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 21 (8), 1788-1800
- https://doi.org/10.1096/fj.06-7451com
Abstract
Hepatic ischemia-reperfusion (I/R) injury continues to be a fatal complication that can follow liver surgery or transplantation. We have investigated the involvement of the endocannabinoid system in hepatic I/R injury using an in vivo mouse model. Here we report that I/R triggers several-fold increases in the hepatic levels of the endocannabinoids anandamide and 2-arachidonoylglycerol, which originate from hepatocytes, Kupffer, and endothelial cells. The I/R-induced increased tissue endocannabinoid levels positively correlate with the degree of hepatic damage and serum TNF-alpha, MIP-1alpha, and MIP-2 levels. Furthermore, a brief exposure of hepatocytes to various oxidants (H2O2 and peroxynitrite) or inflammatory stimuli (endotoxin and TNF-alpha) also increases endocannabinoid levels. Activation of CB2 cannabinoid receptors by JWH133 protects against I/R damage by decreasing inflammatory cell infiltration, tissue and serum TNF-alpha, MIP-1alpha and MIP-2 levels, tissue lipid peroxidation, and expression of adhesion molecule ICAM-1 in vivo. JWH133 also attenuates the TNF-alpha-induced ICAM-1 and VCAM-1 expression in human liver sinusoidal endothelial cells (HLSECs) and the adhesion of human neutrophils to HLSECs in vitro. Consistent with the protective role of CB2 receptor activation, CB2-/- mice develop increased I/R-induced tissue damage and proinflammatory phenotype. These findings suggest that oxidative/nitrosative stress and inflammatory stimuli may trigger endocannabinoid production, and indicate that targeting CB2 cannabinoid receptors may represent a novel protective strategy against I/R injury. We also demonstrate that CB2-/- mice have a normal hemodynamic profile.Keywords
Funding Information
- National Institute on Alcohol Abuse and Alcoholism
This publication has 70 references indexed in Scilit:
- Nitric Oxide and Peroxynitrite in Health and DiseasePhysiological Reviews, 2007
- The Endocannabinoid System as an Emerging Target of PharmacotherapyPharmacological Reviews, 2006
- Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditionsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Cirrhotic cardiomyopathy: an endocannabinoid connection?British Journal of Pharmacology, 2005
- Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemiaNeuroscience, 2004
- Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in HypertensionCirculation, 2004
- Drug-Induced Hypothermia Reduces Ischemic DamageStroke, 2003
- Release of Fatty Acid Amides in a Patient With Hemispheric StrokeStroke, 2002
- Sequential observation of micrometastasis formation by bacterial lacZ gene-tagged Lewis lung carcinoma cellsCancer Letters, 1997
- Occurrence and postmortem generation of anandamide and other long‐chain N‐acylethanolamines in mammalian brainFEBS Letters, 1995